RT Journal Article
SR Electronic
T1 Wearables to monitoring the activities daily living in patients post-hospitalization by COVID-19
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP PA2271
DO 10.1183/13993003.congress-2021.PA2271
VO 58
IS suppl 65
A1 Frade, Maria Cecília Moraes
A1 Beltrame, Thomas
A1 Viana, Daiane Roberta
A1 Da Silva, Marcela Maria Carvalho
A1 Gois, Mariana De Oliveira
A1 De Facio, Carina Araujo
A1 Gonzaga, Luana Aprecida
A1 Arcuri, Juliano Ferreira
A1 Di Lorenzo, Valéria Amorim Pires
A1 Catai, Aparecida Maria
YR 2021
UL http://erj.ersjournals.com/content/58/suppl_65/PA2271.abstract
AB Background: COVID-19 causes a significant number of deaths in the world, and 10% of the infected individuals must be hospitalized. After the period of hospitalization, beyond the already known consequences, the patients suffer later complications of COVID-19, which are not yet totally clear. Thereafter, patients’ follow-up monitoring provides a better understanding of COVID-19 systemic consequences.Aim: To analyze the ventilatory and cardiac responses and the level of activity during activities of daily living (ADL) in post-hospitalization patients.Methods: Eight men were included, 4 with post-COVID-19 (48±12.4 years; 79.4±3.3 kg; 167±7.7 cm) and 4 healthy (49±12.2 years; 78.2±10 kg; 176±9.3 cm). Healthy subjects were assessed before the pandemic started. All of them used the smart t-shirt (®Hexoskin) with embedded sensors (Respiratory, Activity, and ECG) during (6.4±1.2 days, 8.3±1.4 hours/day) in their free ADL. Breath rate (BR), minute ventilation (Ve), tidal volume (Tv), heart rate (HR), hip acceleration (Acc), and hip cadence (Cad) were split by active (Acc>0.05) and inactive period (Acc<0.05g).Results: Patients with COVID-19 presented higher mean values of BR and HR and lower values of Ve, Tv, Acc, and Cad, both periods (Fig1).Conclusion: The wearables could be a global assessment tool to monitoring the consequences of COVID-19 during ADL. Fig 1. Data wearables during ADL.FAPESP: 2018/22818-9;2016/22215-7.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA2271.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).